Americas (WHO region) vs Luxembourg: Polio vaccine: inactivated second or third-dose polio vaccine (IPVc)
Americas (WHO region)
85.0%
in 2025
Luxembourg
99.0%
in 2025
Americas (WHO region) rank
3rd
Luxembourg rank
1st
Polio vaccine: inactivated second or third-dose polio vaccine (IPVc) over time
- Americas (WHO region)
- Luxembourg
How they compare
Luxembourg currently reports 99.0% against 85.0% in Americas (WHO region), a difference of 14.0%.
That makes Luxembourg's figure about 1.2 times Americas (WHO region)'s.
Across all 5 years both countries report, Luxembourg has been ahead every year.
Americas (WHO region) ranks 3rd and Luxembourg ranks 1st of 11 groups.
Luxembourg has averaged higher in every one of the 1 decades both report.
Frequently asked questions
- Which has higher polio vaccine: inactivated second or third-dose polio vaccine (ipvc), Americas (WHO region) or Luxembourg?
- Luxembourg, at 99.0% against 85.0% in Americas (WHO region) as of 2025.
- What is the difference in polio vaccine: inactivated second or third-dose polio vaccine (ipvc) between Americas (WHO region) and Luxembourg?
- 14.0%, with Luxembourg ahead.
- How many years of comparable data are there for Americas (WHO region) and Luxembourg?
- 5 years are reported by both, from 2021 to 2025.
- How do Americas (WHO region) and Luxembourg rank globally for polio vaccine: inactivated second or third-dose polio vaccine (ipvc)?
- Americas (WHO region) ranks 3rd and Luxembourg ranks 1st of 11 groups.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Polio vaccine: inactivated second or third-dose polio vaccine (IPVc) immunization coverage by the locally recommended age (%) (WUENIC). Statizoid refreshes it automatically from the source and publishes the full history for both places.